Péter Tenke
- Urology top 0.2%
- Urinary Bladder and Prostate Research 18
- Molecular Medicine top 0.5%
- Epidemiology top 0.5%
- Urinary Tract Infections Management 44
- Clinical Biochemistry top 0.5%
-
- Pelvic floor disorders treatments 14
-
- Prostate Cancer Diagnosis and Treatment 12
- Prostate Cancer Treatment and Research 9
-
- Pediatric Urology and Nephrology Studies 8
-
- Surgical site infection prevention 7
- Bladder and Urothelial Cancer Treatments 5
Péter Tenke
60 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Urology 1.3k
- Applied Microbiology and Biotechnology 329
- Molecular Medicine 689
- Epidemiology 3.1k
- Clinical Biochemistry 494
Countries citing papers authored by Péter Tenke
This map shows the geographic impact of Péter Tenke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Tenke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Tenke more than expected).
Fields of papers citing papers by Péter Tenke
This network shows the impact of papers produced by Péter Tenke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Tenke. The network helps show where Péter Tenke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Péter Tenke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2019 | 12 | |
| 3 | 2019 | 22 | |
| 4 | 2019 | 22 | |
| 5 | Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trialbreakdown → | 2018 | 305 |
| 6 | 2016 | 15 | |
| 7 | 2015 | 64 | |
| 8 | Correlation of Technetium Tc99m trofolastat chloride (MIP-1404) uptake using SPECT/CT with histopathology: A phase 2 study of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) with extended lymph node dissection (ePLND) | 2014 | 2 |
| 9 | 2014 | 73 | |
| 10 | 2013 | 62 | |
| 11 | 2013 | 71 | |
| 12 | 2012 | 56 | |
| 13 | 2012 | 231 | |
| 14 | 2012 | 81 | |
| 15 | 2011 | 123 | |
| 16 | 2006 | 112 | |
| 17 | 2006 | 34 | |
| 18 | 2005 | 103 | |
| 19 | 2004 | 123 | |
| 20 | 1995 | 8 |
About Péter Tenke
Péter Tenke is a scholar working on Urology, Epidemiology, Rheumatology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 65 papers that have together received 4.7k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (44 papers), Urinary Bladder and Prostate Research (18 papers), Pelvic floor disorders treatments (14 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (9 papers), Pediatric Urology and Nephrology Studies (8 papers), Surgical site infection prevention (7 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Urology (1.3k citations), Applied Microbiology and Biotechnology (329 citations), Molecular Medicine (689 citations), Epidemiology (3.1k citations) and Clinical Biochemistry (494 citations). Péter Tenke has collaborated with scholars based in Hungary, Germany and Türkiye. Frequent co-authors include Truls E. Bjerklund Johansen, Kurt G. Naber, Florian Wagenlehner, Béla Köves, Magnus Grabe, Mete Çek, Suzanne E. Geerlings, Anthony J. Schaeffer, Thomas M. Hooton and Sanjay Saint. Their work appears in journals such as World Journal of Urology, International Journal of Antimicrobial Agents, European Urology, Journal of Clinical Oncology and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.